Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160)
05/2003
05/21/2003EP0891316B1 Processes for the manufacture of methylmercaptopropanal
05/21/2003EP0874818B1 Novel substituted aryl compounds useful as modulators of acetylcholine receptors
05/21/2003EP0827943B1 Processes for the reduction of carbonyl compounds
05/21/2003EP0820285B1 Methods and compositions for lipidization of hydrophilic molecules
05/21/2003CN1419583A Method for stabilising silicone elastomer moulds
05/21/2003CN1419539A Amidino compound and salts thereof useful as nitric oxide synahase inhibitors
05/21/2003CN1419537A Insecticidal anthranilamides
05/21/2003CN1419534A Diphenyl ether compounds useful in therapie
05/21/2003CN1419532A Novel fatty acid analogous
05/21/2003CN1109020C Method for separating ammonium sulfate and ammonium hydrogen sulfate and method for producing 2-hydroxyl-4-methyl-thiobutanoic acid using said method
05/20/2003US6566547 Fungicides
05/20/2003US6566509 Compound for use as bactericide
05/20/2003US6565997 Superior in vibration transmittability between ceramic substrate and piezoelectric
05/20/2003US6565830 DTPA monoamides, pharmaceutical agents containing these compounds, their use and process for their production
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003040088A1 Process for preparation of fluorinated sulfides with iodine pentafluoride
05/15/2003WO2003040080A2 Lipoxin a4 analogs
05/15/2003US20030092934 Process for preparing 2-hydroxy-4-methylthiobutanoic acid
05/15/2003US20030092769 Diaryl-enynes
05/15/2003US20030092762 Anti-inflammatory nitro and thia-fatty acids
05/15/2003US20030092747 Secretase inhibitor
05/15/2003US20030092708 Anticholesterol agents; cardiovascular disorders; antilipemic agents
05/15/2003US20030092142 Process for the preparation of chiral alpha-hydroxycarboxylic acids
05/15/2003US20030091587 Bactericides, fungicides, viricides
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/14/2003EP1310477A2 Process for the preparation of chiral alpha-hydroxycarboxylic acids
05/14/2003EP1309548A1 Chiral integrin modulators and methods of use thereof
05/14/2003EP1309541A1 Hydrolysis of acylamino acids
05/14/2003EP1124799B1 Method for preparing methionine
05/14/2003EP0999856B1 Radiopharmaceuticals for imaging infection and inflammation
05/14/2003EP0994840B1 Process for the preparation of 1-aryl-3-cyclopropyl-1,3-propanediones
05/14/2003CN1418219A Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the prepararation of the derivatives
05/14/2003CN1418190A N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
05/14/2003CN1418189A Process for producing 4-bromothioanisole
05/13/2003US6563008 Biphenyl compounds and their use as oestrogenic agents
05/13/2003US6562994 Reacting a substituted halo- or sulfonylbenzene with an alpha, beta unsaturated propanamide; followed by epoxidation, reacting with a thiol and oxidizing; no chromatographic separations; uses less expensive starting materials
05/13/2003US6562861 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
05/13/2003US6562807 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity
05/13/2003US6562613 Recombinant C-proteinase and processes, methods and uses thereof
05/13/2003CA2171569C Methods for preparing normal and overbased phenates
05/13/2003CA2021467C Heterocyclically substituted sulfonylureas, process for their preparation, and their use as herbicides or plant growth regulators
05/08/2003WO2003037854A1 Method of preparing 4-chloro-3-methyl-2-butenylphenyl sulfide, di(4-chloro-3-methyl-2-butenyl)sulfide and di(4-chloro-3-methyl-2-butenyl)sulfone for synthesis of natural carotenoid products
05/08/2003WO2003037853A1 Substituted thioacetamides
05/08/2003US20030088111 Protected forms of pharmacologically active agents and uses therefor
05/08/2003US20030088105 Process for the preparation of substituted thiazolines and their intermediates
05/08/2003US20030087956 Useful in the treatment of disease mediated by the interaction between VCAM-1 and/or fibronectin and the integrin receptor alpha 4 beta 1.
05/08/2003US20030087945 Sulfonylaminocarboxylic acids
05/08/2003US20030087905 Containing a haloalkyl group: e.g., 3-((3-(3-trifluoromethoxyphenoxy) phenyl)((3-(1,1,2,2-tetrafluoroethoxy)phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol
05/08/2003US20030087897 Containing carboxylic acid groups; diagnosis; prophylaxis
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003CA2462206A1 Substituted thioacetamides
05/07/2003EP1308438A1 3-substituted urea derivatives and medicinal use thereof
05/07/2003EP1308437A1 Acylacetonitriles, process for preparation thereof and miticides containing the same
05/07/2003EP1308433A1 Benzhydryl derivatives
05/07/2003EP1307442A2 Method for producing lipoic acid and dihydrolipoic acid
05/07/2003EP1086079B1 Derivatives of hydroxyphenylsulfanylbenzoic and hydroxyphenylsulfanylarylacetic acids
05/07/2003EP0749433B1 (4,4-difluorobut-3-enylthio)-substituted heterocyclic or carbocyclic ring compounds having pesticidal activity
05/07/2003EP0749417B1 Cyano compounds and preparations thereof
05/07/2003CN1416416A Androgen receptor suppressors in treatment of hirsutism,acne and androgenetic alopecia
05/07/2003CA2411218A1 Process for the preparation of chiral alpha-hydroxycarboxylic acids
05/06/2003US6559214 Composition comprising a halogen containing polymer and degradation products of a blocked mercaptan present as the sole heat stabilizer during processing of the composition at an elevated temperature, said products including a free
05/06/2003US6559185 Nitromethyl ketone compounds having aldose reduction inhibiting properties and methods for their use
05/06/2003US6559181 A method to treat endometrial carcinoma, prostate cancer, or prostate hyperplasia comprising administering to a patient in need of such treatment an effective dose of a 3,4-Diphenyl-bicyclo(4.3.0)nonyl compound of formula I
05/02/2003EP1306369A1 Novel sulfur compounds and intermolecular compounds containing the same as the component compound
05/02/2003EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
05/02/2003EP1305282A1 Pleuromutilin derivatives having antibacterial activity
05/02/2003EP1305274A2 Novel c-4 substituted retinoids
05/02/2003EP1305015A1 Substituted styryl benzylsulfones for treating proliferative disorders
05/02/2003EP1056704B1 Antitumor agents
05/01/2003WO2003035603A1 Acetic acid derivatives
05/01/2003WO2003034989A2 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE
05/01/2003WO2002100295A3 Facially amphiphilic polymers as anti-infective agents
05/01/2003US20030083505 Benzenedicarboxylic acid derivatives
05/01/2003US20030083382 Orally administered dosage forms of GABA analog prodrugs having reduced toxicity
05/01/2003US20030083374 NAALADase inhibitors useful as pharmaceutical compounds and compositions
05/01/2003US20030083356 Statine derivatives for the treatment of Alzheimer's disease
05/01/2003US20030083353 Beta-secretase inhibitors
05/01/2003US20030083331 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/01/2003US20030083267 For inhibiting the binding of ligands to antigens; prophylaxis and treatment of inflammatory and autoimmune diseases such as asthma, arthritis, psoriasis, transplantation rejection, multiple sclerosis, diabetes, and inflammatory bowel disease
05/01/2003US20030083266 Administering N-acetyl cysteine ethyl ester for prophylaxis of stroke and trauma
05/01/2003US20030082631 Detecting modulator of peroxisome proliferator-activated receptor; obtain sample contain proxisome receptor, incubate with test agent, monitor sample for adjustment in receptor activity
05/01/2003US20030082154 Fusogenic lipids and vesicles
05/01/2003CA2463226A1 Acetic acid derivatives
04/2003
04/29/2003USRE38103 Preferential, nontoxic oxidoreductase inhibitors such as 5-Methanesulfonamido-6-(2,4-difluorophenylthio)-1-indanone administered for prophylaxis of gastrointestinal disorders
04/29/2003US6555714 P-hydrophenylpyruvate dioxygenases (HPPD) from plants is incubated with test substrate and enzymatic activity of enzyme is determined in comparison with activity of uninhibited enzyme
04/29/2003US6555712 Process for the preparation of diorganotrisulfide
04/29/2003US6555705 Thermosensitive recording material and phthalic acid derivatives for use in the same
04/29/2003US6555700 1,3-propane diol esters and ethers and methods for their use in drug delivery
04/29/2003US6555690 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
04/29/2003US6555562 2-Carboxybenzoyl-(N'-3,5-dichloroisonicotinoyl)-L-4aminophenyl alanine, for example; inhibit the binding of alpha-4 integrins to their ligands, use to treat immune or inflammatory disorders
04/24/2003WO2003033470A1 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
04/24/2003WO2003033453A1 Dicarboxylic acid derivatives, their preparation and therapeutical use
04/24/2003WO2003033447A1 Luminous compounds and labeling reagents using the same
04/24/2003WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/24/2003US20030078447 Tetracyclic and pentacyclic compounds, and their use in liquid-crystalline media
04/24/2003US20030078440 O- or S- substituted tetrahydronaphthalene derivatives useful as regulators of cell proliferation and differentiation, useful for treating skin-related diseases
04/24/2003US20030078436 Process for the catalytic preparation of N-acylglycine derivatives
04/24/2003US20030078299 Anti-cancer nitro- and thia-fatty acids
04/24/2003US20030078287 For controlling plant and animal pests
1 ... 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 ... 272